DOCSLIB.ORG

Seminal CD38 Is a Pivotal Regulator for Fetomaternal Tolerance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Seminal CD38 Is a Pivotal Regulator for Fetomaternal Tolerance Seminal CD38 is a pivotal regulator for fetomaternal tolerance Byung-Ju Kima,b, Yun-Min Choia,b, So-Young Raha,b, Dae-Ryoung Parka,b, Seon-Ah Parka, Yun-Jo Chunga, Seung-Moon Parkc, Jong Kwan Parkd, Kyu Yun Jange, and Uh-Hyun Kima,b,f,1 + aNational Creative Research Laboratory for Ca2 Signaling Network and Departments of bBiochemistry, dUrology, and ePathology, Chonbuk National University Medical School, Jeonju, 561-180, Korea; cDivision of Biotechnology, College of Environmental and Bioresource Sciences, Chonbuk National University, Iksan, 570-752, Korea; and fInstitute of Cardiovascular Research, Chonbuk National University, Jeonju, 561-180, Korea Edited by John J. Eppig, The Jackson Laboratory, Bar Harbor, ME, and approved December 22, 2014 (received for review July 16, 2014) A successful pregnancy depends on a complex process that estab- a variety of inflammatory diseases (20–23). For example, recombi- lishes fetomaternal tolerance. Seminal plasma is known to induce nant CD38 inhibits LPS-induced inflammatory signals in mouse maternal immune tolerance to paternal alloantigens, but the seminal macrophages and human DCs through an interaction with CD31 factors that regulate maternal immunity have yet to be characterized. (24, 25). Here, we show that a soluble form of CD38 (sCD38) released from In this study, we found that CD38 is truncated and released seminal vesicles to the seminal plasma plays a crucial role in inducing into the seminal plasma from seminal vesicles (SVs) as a soluble + + + tolerogenic dendritic cells and CD4 forkhead box P3 (Foxp3 )reg- form (sCD38) in humans and mice. This finding prompted us to ulatory T cells (Tregs), thereby enhancing maternal immune tolerance examine whether CD38 plays a role in maternal immune toler- and protecting the semiallogeneic fetus from resorption. The abortion −/− ance during pregnancy. We found that sCD38 present in seminal rate in BALB/c females mated with C57BL/6 Cd38 males was high plasma was crucial for the induction of uterine tDC and Tregs, compared with that in females mated with Cd38+/+ males, and this + which are responsible for the development of the fetomaternal was associated with a reduced proportion of Tregs within the CD4 tolerance. T-cell pool. Direct intravaginal injection of sCD38 to CBA/J pregnant mice at preimplantation increased Tregs and pregnancy rates in mice Results under abortive sonic stress from 48 h after mating until euthanasia. CD38 Is Truncated and Released from SVs to the Plasma as a Soluble MEDICAL SCIENCES Thus, sCD38 released from seminal vesicles to the seminal plasma acts Form. ADPRC activity was detected in human seminal fluid in as an immunoregulatory factor to protect semiallogeneic fetuses from two proteins with molecular weights of 45 kDa and 37 kDa as maternal immune responses. identified in in-gel assays (Fig. 1A). Notably, the 37 kDa protein bound to a CD38 immunoaffinity column (Fig. 1B, lanes 1 and seminal plasma | CD38 | regulatory T cells | dendritic cells | fetomaternal 3), whereas the 45 kDa protein did not (Fig. 1B, lanes 2 and 4). tolerance This suggests that the 37 kDa protein was a truncated form of CD38, whereas the 45 kDa protein was full-length CD38, which eventy-five percent of pregnancies that are lost represent is encapsulated within prostasomes (13), making the CD38 (45 Sfailure of implantation and are therefore not clinically rec- kDa) physically inaccessible for binding to the affinity column. ognized as pregnancies (1). Recurrent miscarriage (the sponta- Aminoterminal sequencing of the 37 kDa protein identified its neous loss of three or more consecutive pregnancies) is a – cleavage site as Arg58 close to the TM domain of CD38 (Fig. significant health issue for 1 2% of women, with no identifiable 1C). Western blot analysis with two different antibodies against biological cause and no effective treatment. During early stages CD38 peptides (CD3845–57 and CD38171–292) confirmed that this of pregnancy, complex processes help to create a uterine envi- was the case (Fig. 1D). The soluble form, 37 kDa CD38 (sCD38), ronment that is conducive to a successful pregnancy. These was detected in all 19 seminal plasma samples tested (range, include immunological adaptation to the semiallogeneic fetus. Tolerance to paternal alloantigens is critical for successful re- Significance production in placental mammals (2, 3). Many studies have proposed that regulatory T cells (Tregs) play an essential role in the development of fetomaternal tolerance in mice and humans In natural matings, semen delivers spermatozoa and immuno- (4–7). Seminal plasma contains potent immunoregulatory mol- regulatory fluids to the female reproductive tract. Here, a sol- ecules that contribute to the induction of tolerogenic DCs uble form of CD38 (sCD38) is shown to play an important role (tDCs) and ultimately Treg expansion, which is necessary to in facilitating maternal immune tolerance against the fetus by inducing the development of uterine tolerogenic DCs and establish maternal tolerance against paternal antigens (8–10). + + However, the specific molecules in semen that are responsible forkhead box P3 (Foxp3 ) regulatory T cells. Deficiency of for expansion of Tregs and establishment of maternal tolerance sCD38 in seminal fluid increased the rates of loss of allogeneic remain undefined. fetuses, and this loss was rescued by a direct injection of CD38, a mammalian prototype of ADP ribosyl cyclases recombinant sCD38 into the uterus. Thus, seminal sCD38 acts as a pivotal immune suppressor for establishing maternal (ADPRCs), is a type II transmembrane (TM) glycoprotein immune tolerance against the fetus. sCD38 could potentially expressed in many cell types and seminal fluid (11–16). CD38 be used to prevent failed pregnancies. produces calcium-mobilizing second messengers, cyclic ADP ri- bose, and nicotinic acid adenine dinucleotide phosphate (11, 12). Author contributions: B.-J.K. and U.-H.K. designed research; B.-J.K., Y.-M.C., S.-Y.R., We previously showed that intact CD38 in prostasomes assists D.-R.P., S.-A.P., Y.-J.C., S.-M.P., J.K.P., and K.Y.J. performed research; B.-J.K., K.Y.J., + progesterone-induced sperm Ca2 signaling (13). In addition to and U.-H.K. analyzed data; and B.-J.K. and U.-H.K. wrote the paper. 2+ its enzymatic role for Ca signaling, CD38 may also have a The authors declare no conflict of interest. nonenzymatic role through its interaction with CD31 (17, 18). This article is a PNAS Direct Submission. CD31, a type I TM homophilic or heterophilic receptor, is 1To whom correspondence should be addressed. Email: [email protected]. expressed in endothelial cells and a variety of immune cells (19) This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. and is involved in attenuating the inflammatory response in 1073/pnas.1413493112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1413493112 PNAS Early Edition | 1of6 Downloaded by guest on September 29, 2021 Cd38−/− b A 1 2 B 1 2 3 4 with or wild-type C57BL/6 (H-2 ) male mice. Mice were examined at 12.5 d postcoitum (dpc), at which time both implan- tation and resorption would be visible. We found that female mice −/− −/− mated with Cd38 males (Cd38 matings) showed higher rates –45 kDa Cd38+/+ –45 kDa –37 kDa of fetal resorption at 12.5 dpc than females mated with –37 kDa P = 0.015 45-57 171-292 AC40 n.s. C 12 12 P = 0.003 10 10 CD38 ID TM ED 30 8 8 58 20 6 6 sCD38 RFPETV 4 4 10 % Resorption 2 = 9 2 = 13 n= 13 n= n= 9 n= n n= 13 n= n= 9 n= 0 n 0 0 D E site implantation Total -/- -/- -/- Viable implantation site Viable implantation Cd38 Cd38 Cd38 HC HC 45 kDa CD38 42 kDa x 40 x 200 x 400 37 kDa sCD38 B 34 kDa Ib Ib Ib jz Epitope : 45-57 171-292 3 mm jz Fig. 1. Identification of sCD38 in seminal fluid by in-gel ADPRC assay. (A) Visualization of human seminal fluid proteins with ADPRC activity (lanes 1 De and 2 for two healthy volunteers). (B) Coomassie blue staining of proteins Wild-typematings 500 m 100 m 50 m 50 m eluted from a CD38 immunoaffinity column (lane 1) and proteins that passed Ib / jz Ib jz through the column (lane 2). In-gel ADPRC activity assay for the proteins 3 mm Ib matings eluted from the column (lane 3) and passed through the column (lane 4). (C) -/- jz Upper diagram shows the intracellular domain (ID), TM domain, and extra- De Cd38 cellular domain (ED) of CD38, and the lower diagram shows the N-terminal 500 m 100 m 50 m 50 m amino acid (aa) sequence (highlighted in red) of sCD38. The segments (aa – – MHCII CD80 P = 0.015 P = 0.04 45 57 and aa 171 292) denoted by green lines represent epitopes of the D 200 60 antibodies used for immunoblotting. The dotted line indicates the cleavage (MFI) 50 (MFI) + 150 site within CD38. (D) Proteins immunoprecipitated from seminal fluid and + 40 prostasome lysates using anti-CD38 antibodies were blotted with antibodies 100 30 – – /CD11c specific for two different epitopes: amino acids 45 57 and 171 292. HC, + /CD11c 20 50 + heavy chain of Ig. (E) Mouse seminal plasma was collected from B6 females 10 Events MHCII by uterine lavage within 1 h of mating with B6 intact (CON), vasectomised CD80 0 1 2 3 4 0 1 2 3 4 0 0 (VAS), and SVX males immunoprecipitated with anti-CD38, and the immu- 10 10 10 10 10 10 10 10 10 10 -/- -/- Isotype Wild-type matings Cd38 Cd38 noprecipitates were analyzed for CD38 by Western blotting. Mouse sple- Cd38-/- matings nocyte lysate (SP) and recombinant mouse sCD38 (sCD38) were included in the experiment as size references of full length and truncated sCD38.
Load more

Recommended publications
  • Comparative Transcriptome Analysis of Embryo Invasion in the Mink Uterus
    Placenta 75 (2019) 16–22 Contents lists available at ScienceDirect Placenta journal homepage: www.elsevier.com/locate/placenta Comparative transcriptome analysis of embryo invasion in the mink uterus T ∗ Xinyan Caoa,b, , Chao Xua,b, Yufei Zhanga,b, Haijun Weia,b, Yong Liuc, Junguo Caoa,b, Weigang Zhaoa,b, Kun Baoa,b, Qiong Wua,b a Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, China b State Key Laboratory for Molecular Biology of Special Economic Animal and Plant Science, Chinese Academy of Agricultural Sciences, Changchun, China c Key Laboratory of Embryo Development and Reproductive Regulation of Anhui Province, College of Biological and Food Engineering, Fuyang Teachers College, Fuyang, China ABSTRACT Introduction: In mink, as many as 65% of embryos die during gestation. The causes and the mechanisms of embryonic mortality remain unclear. The purpose of our study was to examine global gene expression changes during embryo invasion in mink, and thereby to identify potential signaling pathways involved in implantation failure and early pregnancy loss. Methods: Illumina's next-generation sequencing technology (RNA-Seq) was used to analyze the differentially expressed genes (DEGs) in implantation (IMs) and inter- implantation sites (inter-IMs) of uterine tissue. Results: We identified a total of 606 DEGs, including 420 up- and 186 down-regulated genes in IMs compared to inter-IMs. Gene annotation analysis indicated multiple biological pathways to be significantly enriched for DEGs, including immune response, ECM complex, cytokine activity, chemokine activity andprotein binding. The KEGG pathway including cytokine-cytokine receptor interaction, Jak-STAT, TNF and the chemokine signaling pathway were the most enriched.
    [Show full text]
  • IL-10-Null Mice Inflammation-Induced Fetal Demise in Uterine NK Cells Mediate
    Uterine NK Cells Mediate Inflammation-Induced Fetal Demise in IL-10-Null Mice This information is current as Shaun P. Murphy, Loren D. Fast, Nazeeh N. Hanna and of September 27, 2021. Surendra Sharma J Immunol 2005; 175:4084-4090; ; doi: 10.4049/jimmunol.175.6.4084 http://www.jimmunol.org/content/175/6/4084 Downloaded from References This article cites 52 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/175/6/4084.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Uterine NK Cells Mediate Inflammation-Induced Fetal Demise in IL-10-Null Mice Shaun P. Murphy,* Loren D. Fast,† Nazeeh N. Hanna,‡ and Surendra Sharma2* Specialized NK cells are recruited in high numbers to the mammalian embryo implantation sites, yet remain pregnancy com- patible.
    [Show full text]
  • Role of Some Cytokines on Reproduction
    Middle East Fertility Society Journal (2011) 16, 220–223 Middle East Fertility Society Middle East Fertility Society Journal www.mefsjournal.com www.sciencedirect.com ORIGINAL ARTICLE Role of some cytokines on reproduction Batool Mutar Mahdi * Department of Microbiology, Al-Kindy College of Medicine, Baghdad University, AL-Nahda Square, Baghdad, Iraq Received 11 December 2010; accepted 13 March 2011 Available online 9 April 2011 KEYWORDS Abstract Background: The etiology of female reproductive failure may be very complex owing to Infertility; a neuro-endocrine-immune association. Dysregulated immunity has been implicated in reproductive Cytokines; failure. Lower TH1 cytokines is supportive for physiological pregnancy. IL-10; Aim of the study: To measure serum levels of pro-inflammatory cytokines (tumor necrosis factor IL-6; (TNF-a), interferon-gamma (IFN-c) and anti-inflammatory cytokines (IL-10 and IL-6) in repro- IFN-c; ductive failure women. TNF-a Patients and methods: A cross- sectional study was carried out in Kammal El-Sammrari Hospital from 2008 to 2010. Forty-five women with reproductive failure participated in the study. Serum lev- els of cytokines (IL-6, IL-10, TNF-alpha and IFN-gamma) were done by Enzyme Linked Immuno Sorbent Assay (ELISA) and compared with age, body mass index and ethnicity matched thirty fer- tile women. Results: There is a significant increase in IL-10 (18.09) (p = 0.002) and IFN-c (49.62) (p = 0.0001) in women with reproductive failure. TNF-a and IL-6 showed no significance different with fertile group. Conclusions: There is increase in IL-10 and IFN-c in women with reproductive failure.
    [Show full text]
  • For Review Only 19 10 Telephone: +44 1223 333729 20 21 Fax: +44 1223 333346
    Submitted to Phil. Trans. R. Soc. B - Issue The role of the maternal immune system in the regulation of human birth weight For ReviewJournal: Philosophical Only Transactions B Manuscript ID: RSTB-2014-0071.R1 Article Type: Review Date Submitted by the Author: n/a Complete List of Authors: Moffett, Ashley; University of Cambridge, Pathology Hiby, Susan; University of Cambridge, Pathology Sharkey, Andrew; University of Cambridge, Pathology Issue Code: Click <a href=http://rstb.royalsocietypublishing.org/site/misc/issue- BIRTH codes.xhtml target=_new>here</a> to find the code for your issue.: Developmental biology < BIOLOGY, Evolution Subject: < BIOLOGY, Genetics < BIOLOGY, Immunology < BIOLOGY Birth weight, Natural Killer (NK) cells, Keywords: Immunology, pre-eclampsia, fetal growth restriction, placental development http://mc.manuscriptcentral.com/issue-ptrsb Page 1 of 27 Submitted to Phil. Trans. R. Soc. B - Issue 1 1 2 3 4 5 The role of the maternal immune system in the regulation of 6 7 human birth weight 8 9 10 1,2 1 1 11 5 Ashley Moffett , Susan E . Hiby and Andrew Sharkey 12 1 Department of Pathology and Centre for Trophoblast Research, 13 14 University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK 15 16 17 2Corresponding author. E-mail address: [email protected] (A. Moffett). 18 For Review Only 19 10 Telephone: +44 1223 333729 20 21 Fax: +44 1223 333346. 22 23 24 Summary 25 26 Human birth weight is subject to stabilizing selection. Large babies are at 27 15 risk of obstetric complications such as obstructed labour, which endangers 28 29 both mother and child.
    [Show full text]
  • Early Pregnancy Diagnosis and Embryo/Fetus Mortality
    EARLY PREGNANCY DIAGNOSIS AND EMBRYO/FETUS MORTALITY IN CATTLE A Dissertation by JUAN EDUARDO ROMANO Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY December 2004 Major Subject: Physiology of Reproduction EARLY PREGNANCY DIAGNOSIS AND EMBRYO/FETUS MORTALITY IN CATTLE A Dissertation by JUAN EDUARDO ROMANO Submitted to Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved as to style and content by: _____________________________ _________________________________ Duane C. Kraemer David W. Forrest (Co-Chair of Committee) (Co-Chair of Committee) _____________________________ _________________________________ Mark E. Westhusin James A. Thompson (Member) (Member) _____________________________ John W. McNeill (Head of Department) December 2004 Major Subject: Physiology of Reproduction iii ABSTRACT Early Pregnancy Diagnosis and Embryo/Fetus Mortality in Cattle. (December 2004) Juan Eduardo Romano, D.V.M., University of Uruguay; M.S., University of Minnesota Co-Chairs of Advisory Committee: Dr. Duane C. Kraemer Dr. David W. Forrest Pregnancy diagnosis by transrectal ultrasonography (using a 5 MHZ linear probe) presented the maximum sensitivity and negative predictive values at day 26 and day 29 after estrus in heifers and cows, respectively. Palpation per rectum using the fetal membrane slip for pregnancy diagnosis did not increase embryo/fetus mortality when compared with a positive control group of non-palpated females. The use of a controlled randomized block design was a useful approach to study this problem. Blocking for category and number of embryos allowed us to remove these confounding factors. Factors that affected pregnancy loss during the first four months of pregnancy were: period of pregnancy, age of the animal, number of previous lactations and number of embryos.
    [Show full text]
  • Antibody-Induced Pregnancy Loss
    TNF-α Is a Critical Effector and a Target for Therapy in Antiphospholipid Antibody-Induced Pregnancy Loss This information is current as Jessica Berman, Guillermina Girardi and Jane E. Salmon of September 24, 2021. J Immunol 2005; 174:485-490; ; doi: 10.4049/jimmunol.174.1.485 http://www.jimmunol.org/content/174/1/485 Downloaded from References This article cites 48 articles, 7 of which you can access for free at: http://www.jimmunol.org/content/174/1/485.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 24, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology TNF-␣ Is a Critical Effector and a Target for Therapy in Antiphospholipid Antibody-Induced Pregnancy Loss1 Jessica Berman, Guillermina Girardi, and Jane E. Salmon2 The antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, intrauterine growth restriction, and vascular thrombosis in the presence of antiphospholipid (aPL) Abs.
    [Show full text]
  • Preterm Birth and Preeclampsia Fetal
    The Journal of Immunology TLR9 Provokes Inflammation in Response to Fetal DNA: Mechanism for Fetal Loss in Preterm Birth and Preeclampsia Andrea Scharfe-Nugent,*,1 Sine´ad C. Corr,†,1 Susan B. Carpenter,‡ Louise Keogh,x Brendan Doyle,{ Cara Martin,{ Katherine A. Fitzgerald,‡ Sean Daly,* John J. O’Leary,{,2 and Luke A. J. O’Neill†,2 Preterm birth, the major cause of neonatal mortality in developed countries, is associated with intrauterine infections and inflam- mation, although the exact mechanisms underlying this event are unclear. In this study, we show that circulating fetal DNA, which is elevated in pregnancies complicated by preterm labor or preeclampsia, triggers an inflammatory reaction that results in sponta- neous preterm birth. Fetal DNA activates NF-kB, shown by IkBa degradation in human PBMCs resulting in production of proinflammatory IL-6. We show that fetal resorption and preterm birth are rapidly induced in mice after i.p. injection of CpG or fetal DNA (300 mg/dam) on gestational day 10–14. In contrast, TLR92/2 mice were protected from these effects. Furthermore, this effect was blocked by oral administration of the TLR9 inhibitor chloroquine. Our data therefore provide a novel mechanism for preterm birth and preeclampsia, highlighting TLR9 as a potential therapeutic target for these common disorders of preg- nancy. The Journal of Immunology, 2012, 188: 5706–5712. retermbirth(PTB),definedasdeliverybefore37wk disorders of pregnancy. TLRs are an important class of pathogen gestation, has become an epidemic in developed countries. recognition receptors, which signal during infection to bring about P Indeed, PTB and preeclampsia (PEC) are leading causes of immune reactions that have been implicated in PTB (3).
    [Show full text]
  • Amended Safety Assessment of Hydroquinone and P-Hydroxyanisole As Used in Cosmetics
    Amended Safety Assessment of Hydroquinone and p-Hydroxyanisole as Used in Cosmetics Status: Draft Amended Report for Public Comment Release Date: November 15, 2013 Panel Meeting Date: December 9-10, 2013 The 2013 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A. Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Lillian C. Becker, Scientific Analyst/Writer. © Cosmetic Ingredient Review 1101 17th Street, NW, Suite 412 Washington, DC 20036-4702 ph 202.331.0651 fax 202.331.0088 cirinfo@cir- safety.org Distributed for Comment Only -- Do Not Cite or Quote Commitment & Credibility since 1976 MEMORANDOM To: CIR Expert Panel and Liaisons From: Lillian C. Becker, M.S. Scientific Analyst and Writer Date: November 15, 2013 Subject: Hydroquinone & p-Hydroxyanisole As Used In Nail Products in Cosmetics This is the Draft Report of hydroquinone and p-hydroxyanisole as used in nail products. In March, 2013, the Panel decided to review submitted data accompanying a request to amend the 2010 conclusion to include the use of nail polishes that require UV curing. This data, as well as relevant literature on the use of UV nail lamps, are included in this report. The Panel is to review the presented data and decide if there is sufficient information to come to a conclusion on the use of hydroquinone and p-hydroxyanisole in nail products that require UV curing.
    [Show full text]
  • Amended Safety Assessment of Hydroquinone As Used in Cosmetics
    Amended Safety Assessment of Hydroquinone as Used in Cosmetics Status: Draft Amended Report for Panel Review Release Date: February 21, 2014 Panel Meeting Date: March 17-18, 2014 The 2014 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A. Hill, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Lillian C. Becker, Scientific Analyst/Writer. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 Washington, DC 20036-4702 ph 202.331.0651 fax 202.331.0088 [email protected] i Commitment & Credibility since 1976 MEMORANDOM To: CIR Expert Panel and Liaisons From: Lillian C. Becker, M.S. Scientific Analyst and Writer Date: February 21, 2014 Subject: Hydroquinone As Used In in Cosmetics In December 2013, the Panel tabled the Draft Amended Report of hydroquinone and p- hydroxyanisole as used in nail products for the purpose of collecting more data on the use of UV nail lamps. The papers that were requested have been sent to you by email and are summarized in the appropriate section of the report. A paper that Dr. Liebler asked to review (Hansch et al. 2000) is also included in the email. The previous safety assessments on these ingredients are also included in case more information than what is provided in the summaries is needed.
    [Show full text]
  • Recurrent Pregnancy Loss
    Recurrent Pregnancy Loss November 2017 Version 2 0 ESHRE Early Pregnancy Guideline Development Group [1] Version 2 was published 1 April 2019 and includes a correction in the numbers mentioned in section 4.2 on page 39 (changes were marked in green). No further changes were made as compared to version 1 (published November 2017) DISCLAIMER The European Society of Human Reproduction and Embryology (hereinafter referred to as 'ESHRE') developed the current clinical practice guideline, to provide clinical recommendations to improve the quality of healthcare delivery within the European field of human reproduction and embryology. This guideline represents the views of ESHRE, which were achieved after careful consideration of the scientific evidence available at the time of preparation. In the absence of scientific evidence on certain aspects, a consensus between the relevant ESHRE stakeholders has been obtained. The aim of clinical practice guidelines is to aid healthcare professionals in everyday clinical decisions about appropriate and effective care of their patients. However, adherence to these clinical practice guidelines does not guarantee a successful or specific outcome, nor does it establish a standard of care. Clinical practice guidelines do not override the healthcare professional's clinical judgment in diagnosis and treatment of particular patients. Ultimately, healthcare professionals must make their own clinical decisions on a case-by-case basis, using their clinical judgment, knowledge, and expertise, and taking into account the condition, circumstances, and wishes of the individual patient, in consultation with that patient and/or the guardian or carer. ESHRE makes no warranty, express or implied, regarding the clinical practice guidelines and specifically excludes any warranties of merchantability and fitness for a particular use or purpose.
    [Show full text]
  • The Vanishing Triplet
    her and ot C M h il n d i H s e c i a l n t i l h Chen, Clinics Mother Child Health 2015, 12:4 C Clinics in Mother and Child Health ISSN: 2090-7214 DOI: 10.4172/2090-7214.1000196 Case Report Open Access The Vanishing Triplet Pi-Hua Chen Department of Obstetrics and Gynecology, Shuang Ho Hospital , Taipei Medical University, Taipei, Taiwan Corresponding author: Pi-Hua Chen, Department of Obstetric and Gynecology, Shuang-Ho Hospital, Zhonghe District, New Taipei City, Taiwan,Tel: +886222490088; E-mail: [email protected] Received date: October 8, 2015; Accepted date: October 19, 2015; Published date: October 25, 2015 Copyright: © 2015 Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Vanishing fetuses are frequently encountered in pregnancies results from in vitro fertilization. Ultrasound scans taken at the 4-5th weeks showed multiple gestation has occurred, it frequently happens that more than one amniotic sac can be seen in early pregnancy, whereas a few weeks later there is only one to be seen and the other has disappeared. Whereas the triplet pregnancy evolved into a normal twin gestation, and may further evolve into a singleton gestation. These very high resorption rates, which can be explained on the basis of the intense fetal competition for space, nutrition, or other factors during early gestation with frequent loss of the other fetus. Here, we report a case of a vanishing triplet of spontaneous pregnancy, one fetus vanished in the first month of pregnancy while another fetus disappeared at the end of second month.
    [Show full text]
  • The Success of Early Pregnancy Is Determined by the Action of Fundamental Processes That Take Place in the First Week After Fert
    1 Just Accepted 2 This article has been peer reviewed and accepted for publication. It is in production 3 and has not been edited, so may differ from the final published form. 4 Endogenous lysophosphatidic acid participates in 5 vascularization and decidualization at the maternal- 6 fetal interface in the rat 7 Micaela Sordelli , Jimena Beltrame , Elsa Zotta , Natalia Gomez , Ganna Dmytrenko , 8 Maria Sales , Sandra Blois , Carlos Davio , SilvinaPerez 9 Martinez , Ana Franchi , Maria Ribeiro 10 Abstract 11 Lysophosphatidic acid (LPA) influences several female reproductive functions through 12 G protein-coupled receptors. LPA contributes to embryo implantation via 13 lysophosphatidic type 3 receptor (LPA3). In this study, we investigated the participation 14 of endogenous LPA signaling through LPA3 in vascularization and decidualization, two 15 crucial events at the maternal-fetal interface. Pregnant rats were treated with 16 diacylglycerol pyrophosphate (DGPP), a highly selective antagonist of LPA3, in day 5 17 of gestation. DGPP treatment produced aberrant embryo spacing and increased 18 embryo resorption. Also, LPA3 antagonist decreased the cross sectional length of the 19 uterine and arcuate arteries and induced histological anomalies in the decidua and 20 placentas. Marked hemorrhagic processes, infiltration of immune cells and tissue 21 disorganization were observed in the decidual and placental tissues from resorpted 22 sites. The mRNA expression of interleukin 10 (Il-10), vascular endothelial growth factor 23 (Vegf-a) and vascular endothelial growth factor receptor 1 (Vegf-r1), three 24 vascularization markers, was reduced in resorpted sites from day 8. Our results show 25 that the disruption of endogenous LPA signaling by blocking LPA3 modified the 26 development of uterine vessels with consequences in the formation of the decidua and 27 placenta and in the growth of the embryos.
    [Show full text]